Century Therapeutics Inc

CUSIP 15673T100COMIPSCQ1 2026

13D / 13G Filings

Schedule 13D/13G on record

Beneficial Filers

Distinct reporting persons

Largest Stake

23.2%

Max % of class reported

Institutional Holders

13F filers (latest quarter)

32 filings · latest Feb 17, 2026

#	Filed	Reporting Person	Form	% of Class	Shares	Filing
1	Feb 17, 2026	Point72 Asset Management, L.P.	13G/A	6.8%	5.96M	SEC
2	Jan 16, 2026	Commodore Capital LP	13G	11.0%	13.04M	SEC
3	Jan 16, 2026	Venrock Healthcare Capital Partners III, L.P.	13G	7.1%	13.04M	SEC
4	Jan 16, 2026	Ra Capital Management, L.P.	13G	9.9%	17.94M	SEC
5	Jan 15, 2026	Tcg Crossover Gp II, LLC	13G	11.0%	17.75M	SEC
6	Jan 15, 2026	Deep Track Capital, LP	13G	7.3%	13.49M	SEC
7	Jan 5, 2026	Point72 Asset Management, L.P.	13G	5.4%	4.73M	SEC
8	Nov 14, 2025	Bain Capital Life Sciences Opportunities III, LP	13G/A	4.1%	3.54M	SEC
9	May 15, 2025	Casdin Capital, LLC	13G/A	3.7%	32.12T	SEC
10	Feb 14, 2025	Venrock Healthcare Capital Partners III, L.P.	13G/A	4.7%	3.96M	SEC

See the full Schedule 13D/13G history for Century Therapeutics Inc.

Largest reported positions · latest quarter

#	Fund	Shares	Value
1	Ra Capital Management, L.P.	17.75M	$40.13M
2	Tcg Crossover Management, LLC	17.75M	$39.02M
3	Versant Venture Management, LLC	12.17M	$27.50M
4	Deep Track Capital, LP	9.49M	$21.44M
5	Rtw Investments, LP	8.70M	$19.65M
6	Venrock Adviser, LLC	8.70M	$19.65M
7	Commodore Capital LP	8.70M	$19.65M
8	Point72 Asset Management, L.P.	5.96M	$13.48M
9	Balyasny Asset Management L.P.	5.02M	$11.34M
10	Millennium Management LLC	4.67M	$10.55M